TrialBMC neurology2019

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN).

Li Shen Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.